Bioreactors Market Rapid Growth of Pharmaceuticals and Biotechnology Industries

According to The Insight Partners market research study on "Bioreactors Market to 2027 - Global Analysis and Forecasts by Cell, Molecule, Technology, and End User". The global bioreactors market is expected to reach US$ 5,169.01 Mn by 2027 from US$ 2,958.50 Mn in 2019. The market is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report provides trends prevailing in the global bioreactors market and the factors driving or restraining the market growth.

The global bioreactors market, based on molecule, is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy, and others. The monoclonal antibodies segment held the largest share of the market in 2019. However, stem cell segment is estimated to register the highest CAGR in the market during the forecast period.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPHE100000880/?utm_source=OpenPR&utm_medium=10144

In recent years, the pharmaceutical industry has been growing at anunprecedented pace. Big pharmaceutical companies and contract researchorganizations (CROs) are coming up with new medicines and therapy forms totreat a wide range of indications.

The biopharmaceuticals market is increasing. The strong demand forbiologics and biosimilars has driven the growth of the industry. Thebiopharmaceutical industry is one of the most significant contributors to theeconomy. The US is the largest market for biopharmaceuticals and leader inbiopharmaceutical R&D. As per the Pharmaceutical Research and ManufacturersAssociation (PhRMA), the US firms conduct over half the world's R&D inpharmaceuticals (US$ 75 billion) and hold the highest number of patents in newmedicines. Besides development economies, there have been rapid growthwitnesses in the research environment in emerging economies such as Brazil,China, and India. Factors such as increasing biologics approval, growingbiosimilar pipeline, and increasing investment in research activities are primefactors facilitating the growth of the industry.

The growth of the bioreactors market is attributed to the increasing research and development activities and rising number of biochemical processes across various domains. Leading companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Merck KGaA, Sartorius AG, PBS Biotech, Inc., General Electric, Bioengineering AG, Cellexus, Danaher (Pall Corporation), and bbi-biotech GmbH, among others.

A bioreactor is a device or system engineered or manufactured to supportbiologically active environment. These are vessels in which a chemical processesinvolving organisms or biochemically active substances derived from suchorganisms are carried out.The increasing adoption ofsingle-use bioreactors, and rapid growth of the pharmaceuticals andbiotechnology industries are among the prime factors driving the bioreactorsmarket. Additionally,increasing number of technology and distribution collaborations is anticipatedto drive the market growth in the coming years.However, stringent governmentregulations hamper the growth of the market. The developing healthcareinfrastructure and increasing investments by biopharmaceutical companies are projectedgenerate lucrative opportunities for the growth of the market.

The report segments global bioreactors market as follows:

Global Bioreactors Market - By Cell

Mammalian Cells
Bacterial Cells
Yeast Cells
Others
Global Bioreactors Market - By Molecule

Monoclonal Antibodies
Vaccines
Recombinant Proteins
Stem Cells
Gene Therapy
Others
Global Bioreactors Market - By Technology

Wave-Induced Motion SUB
Stirred SUB
Single-Use Bubble Column
Others
Global Bioreactors Market - By End User

Research and Development Organizations
Biopharma Manufacturers
Contract Manufacturing Organizations (CMOs)

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPHE100000880/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.